BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33038230)

  • 1. Arrhythmogenic substrate detection in chronic ischaemic patients undergoing ventricular tachycardia ablation using multidetector cardiac computed tomography: compared evaluation with cardiac magnetic resonance.
    Jáuregui B; Soto-Iglesias D; Zucchelli G; Penela D; Ordóñez A; Terés C; Chauca A; Acosta J; Fernández-Armenta J; Linhart M; Perea RJ; Prat-González S; Bosch X; Ortiz-Pérez JT; Mont L; Berruezo A
    Europace; 2021 Jan; 23(1):82-90. PubMed ID: 33038230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Ablation cardiac Magnetic resonance to assess Ventricular Tachycardia recurrence (PAM-VT study).
    Roca-Luque I; Vázquez-Calvo S; Garre P; Ortiz-Perez JT; Prat-Gonzalez S; Sanchez-Somonte P; Ferro E; Quinto L; Alarcón F; Althoff T; Perea RJ; Figueras I Ventura RM; Guasch E; Tolosana JM; Lorenzatti D; Morr-Verenzuela CI; Porta-Sanchez A; Arbelo E; Sitges M; Brugada J; Mont L
    Eur Heart J Cardiovasc Imaging; 2024 Jan; 25(2):188-198. PubMed ID: 37819047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac magnetic resonance to predict recurrences after ventricular tachycardia ablation: septal involvement, transmural channels, and left ventricular mass.
    Quinto L; Sanchez P; Alarcón F; Garre P; Zaraket F; Prat-Gonzalez S; Ortiz-Perez JT; JesúsPerea R; Guasch E; Tolosana JM; San Antonio R; Arbelo E; Sitges M; Brugada J; Berruezo A; Mont L; Roca-Luque I
    Europace; 2021 Sep; 23(9):1437-1445. PubMed ID: 34142121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-based criteria to identify the presence of epicardial arrhythmogenic substrate in patients with transmural myocardial infarction.
    Soto-Iglesias D; Acosta J; Penela D; Fernández-Armenta J; Cabrera M; Martínez M; Vassanelli F; Alcaine A; Linhart M; Jáuregui B; Efimova E; Perea RJ; Prat-González S; Ortiz-Pérez JT; Bosch X; Mont L; Camara O; Berruezo A
    Heart Rhythm; 2018 Jun; 15(6):814-821. PubMed ID: 29427821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scar conducting channel characterization to predict arrhythmogenicity during ventricular tachycardia ablation.
    Sanchez-Somonte P; Garre P; Vázquez-Calvo S; Quinto L; Borràs R; Prat S; Ortiz-Perez JT; Steghöfer M; Figueras I Ventura RM; Guasch E; Tolosana JM; Arbelo E; Brugada J; Sitges M; Mont L; Roca-Luque I
    Europace; 2023 Mar; 25(3):989-999. PubMed ID: 36607130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T; Ghasabeh MA; Assis FR; Chrispin J; Keramati A; Misra S; Berger R; Calkins H; Kamel I; Nazarian S; Zimmerman S; Tandri H
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007546. PubMed ID: 30354675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular scar channel entrances identified by new wideband cardiac magnetic resonance sequence to guide ventricular tachycardia ablation in patients with cardiac defibrillators.
    Roca-Luque I; Van Breukelen A; Alarcon F; Garre P; Tolosana JM; Borras R; Sanchez P; Zaraket F; Doltra A; Ortiz-Perez JT; Prat-Gonzalez S; Perea RJ; Guasch E; Arbelo E; Berruezo A; Sitges M; Brugada J; Mont L
    Europace; 2020 Apr; 22(4):598-606. PubMed ID: 32101605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia.
    Yamashita S; Sacher F; Mahida S; Berte B; Lim HS; Komatsu Y; Amraoui S; Denis A; Derval N; Laurent F; Sermesant M; Montaudon M; Hocini M; Haïssaguerre M; Jaïs P; Cochet H
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):699-708. PubMed ID: 26918883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of imaging in catheter ablation of ventricular arrhythmias.
    Berruezo A; Penela D; Jáuregui B; Soto-Iglesias D
    Pacing Clin Electrophysiol; 2021 Jun; 44(6):1115-1125. PubMed ID: 33527461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late gadolinium enhancement cardiac magnetic resonance imaging of ablation lesions after postinfarction ventricular tachycardia ablation: Implications for ventricular tachycardia recurrence.
    Ghannam M; Liang J; Attili A; Cochet H; Jais P; Latchamsetty R; Jongnarangsin K; Morady F; Bogun F
    J Cardiovasc Electrophysiol; 2022 Apr; 33(4):715-721. PubMed ID: 35066968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement between gadolinium-enhanced cardiac magnetic resonance and electro-anatomical maps in patients with non-ischaemic dilated cardiomyopathy and ventricular arrhythmias.
    Torri F; Czimbalmos C; Bertagnolli L; Oebel S; Bollmann A; Paetsch I; Jahnke C; Arya A; Merkely B; Hindricks G; Dinov B
    Europace; 2019 Sep; 21(9):1392-1399. PubMed ID: 31102521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmia ablation lesions detectability and temporal changes on cardiac magnetic resonance.
    Vunnam R; Maheshwari V; Jeudy J; Ghzally Y; Imanli H; Abdulghani M; Mahat JB; Timilsina S; Restrepo A; See V; Shorofsky S; Dickfeld T
    Pacing Clin Electrophysiol; 2020 Mar; 43(3):314-321. PubMed ID: 32052461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia.
    Hennig A; Salel M; Sacher F; Camaioni C; Sridi S; Denis A; Montaudon M; Laurent F; Jais P; Cochet H
    Europace; 2018 Sep; 20(FI2):f179-f191. PubMed ID: 29069369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction.
    Jáuregui B; Soto-Iglesias D; Penela D; Acosta J; Fernández-Armenta J; Linhart M; Ordóñez A; San Antonio R; Terés C; Chauca A; Carreño JM; Scherer C; Falasconi G; Prat-González S; Perea RJ; Mont L; Bosch X; Ortiz-Pérez JT; Berruezo A
    Europace; 2022 Jul; 24(6):938-947. PubMed ID: 34849726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular tachycardia ablation guided or aided by scar characterization with cardiac magnetic resonance: rationale and design of VOYAGE study.
    Lilli A; Parollo M; Mazzocchetti L; De Sensi F; Rossi A; Notarstefano P; Santoro A; Aquaro GD; Cresti A; Lapira F; Faggioni L; Tessa C; Pauselli L; Bongiorni MG; Berruezo A; Zucchelli G
    BMC Cardiovasc Disord; 2022 Apr; 22(1):169. PubMed ID: 35421939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Magnetic Resonance-Guided Ventricular Tachycardia Substrate Ablation.
    Soto-Iglesias D; Penela D; Jáuregui B; Acosta J; Fernández-Armenta J; Linhart M; Zucchelli G; Syrovnev V; Zaraket F; Terés C; Perea RJ; Prat-González S; Doltra A; Ortiz-Pérez JT; Bosch X; Camara O; Berruezo A
    JACC Clin Electrophysiol; 2020 Apr; 6(4):436-447. PubMed ID: 32327078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiac magnetic resonance septal late gadolinium enhancement patterns for periaortic ventricular tachycardia ablation: Heterogeneity of the anteroseptal substrate in nonischemic cardiomyopathy.
    Nishimura T; Patel HN; Wang S; Upadhyay GA; Smith HL; Ozcan C; Shatz DY; Nayak HM; Patel AR; Tung R
    Heart Rhythm; 2021 Apr; 18(4):579-588. PubMed ID: 33301979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.
    Xie S; Desjardins B; Kubala M; Liang J; Yang J; van der Geest RJ; Schaller R; Riley M; Callans D; Zado E; Marchlinski F; Nazarian S
    Heart Rhythm; 2018 Jul; 15(7):987-993. PubMed ID: 29501666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging.
    le Polain de Waroux JB; Pouleur AC; Goffinet C; Pasquet A; Vanoverschelde JL; Gerber BL
    Eur Heart J; 2008 Oct; 29(20):2544-51. PubMed ID: 18762553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.